HEAT BIOLOGICS, INC. Business Finance Contracts & Agreements
75 Contracts & Agreements
- Assignment Agreements (5 contracts)
- Exchange Agreements (2)
- Funding Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (10)
- Note Agreements (3)
- Purchase Agreements (1)
- Registration Rights Agreements (3)
- Stock Agreements (15)
- Subscription Agreements (1)
- Underwriting Agreements (13)
- Warrant Agreements (20)
- Amendment No. 7 to the Rights Agreement dated as of March 11, 2024 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 13, 2024)
- Underwriting Agreement dated March 7, 2024 (Filed With SEC on March 11, 2024)
- Patent Rights Sale and Assignment Agreement between NightHawk Biosciences, Inc. and Kopfkino IP, LLC (Filed With SEC on January 30, 2024)
- Note in the principal amount of $2,250,000 issued to Elusys Holdings Inc (Filed With SEC on January 30, 2024)
- Form of Convertible Note (Filed With SEC on December 12, 2023)
- Amendment No. 6 to the Rights Agreement dated as of December 11, 2023 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8,... (Filed With SEC on December 12, 2023)
- Asset and Equity Interests Purchase Agreement by and between NightHawk Biosciences, Inc. and Elusys Holdings Inc., dated as December 11, 2023 (Filed With SEC on December 12, 2023)
- Amendment No. 5 to the Rights Agreement dated as of March 11, 2023 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 13, 2023)
- Amendment No. 4 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 11, 2022)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc.(f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM131-31, UM139) (Filed With SEC on March 11, 2022)
- Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UMC-131, UMC-139)... (Filed With SEC on March 11, 2022)
- Form of New Non-Statutory Stock Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)
- Form of Amended and Restated Restricted Stock Agreement (Filed With SEC on December 15, 2021)
- Amendment No. 3 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 12, 2021)
- Form of Restricted Stock Agreement (Filed With SEC on January 6, 2021)
- Form of Exchange Agreement (Filed With SEC on March 3, 2020)
- Form of Warrant (Filed With SEC on January 21, 2020)
- Underwriting Agreement, dated January 16, 2020, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 21, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 13, 2020)
- Form of Heat Biologics, Inc. Restricted Stock Agreement (Filed With SEC on January 3, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 25, 2019)
- Amendment No. 1 to the Rights Agreement dated as of March 8, 2019 to the Rights Agreement dated March 11, 2018 by and between Heat Biologics, Inc. and Continental Stock Transfer &... (Filed With SEC on March 12, 2019)
- Heat Biologics, Inc. Form of Restricted Stock Agreement (Filed With SEC on January 3, 2019)
- Form of Warrant (Filed With SEC on November 21, 2018)
- Underwriting Agreement, dated November 21, 2018, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on November 21, 2018)
- Common Warrant (Filed With SEC on May 7, 2018)
- Underwriting Agreement by and between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (A.G.P.), as representative of the underwriters, dated May 2, 2018 (Filed With SEC on May 7, 2018)
- Form of Common Warrant (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on May 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on April 19, 2018)
- Common Stock Sales Agreement, dated January 18, 2018, by and between Heat Biologics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 19, 2018)
- Underwriting Agreement, dated November 17, 2017, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on November 17, 2017)
- Form of Subscription Rights Certificate (Filed With SEC on September 15, 2017)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM03-31, UM05-39) (Filed With SEC on May 3, 2017)
- Funding Commitment issued by Heat Biologics, Inc. dated April 6, 2017 (Filed With SEC on April 7, 2017)